Nanocarriers Market Analysis Through 2030: Market Size, Growth Trends And Industry Outlook
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Nanocarriers Market Poised To Hit $26.74 Billion By 2030 With A 18.1% CAGR
The nanocarriers market size has seen rapid growth in recent years. It is forecast to expand from $11.61 billion in 2025 to $13.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.4%. The growth observed in prior periods can be attributed to breakthroughs in nanotechnology research, increasing investments in pharmaceutical R&D, a rising demand for improved drug bioavailability, the early adoption of nanoparticle-based therapeutics, and the expansion of academic and clinical research.
The nanocarriers market is projected for rapid expansion over the coming years, expected to reach $26.74 billion by 2030 with a compound annual growth rate (CAGR) of 18.1%. This growth during the forecast period is primarily fueled by increasing demand for personalized therapeutics, higher investments in advanced drug delivery systems, the broadened application of nanocarriers in oncology and gene therapy, a heightened focus on minimizing drug side effects, and continuous innovation in nanoscale engineering. Notable trends for this period involve the accelerating development of targeted drug delivery platforms, the increasing uptake of lipid and polymeric nanocarriers, a growing emphasis on controlled and sustained release systems, the expanded use of nanocarriers in gene and vaccine delivery, and enhanced integration with precision medicine methodologies.
Get A Free Sample Report With In-Depth Market Insights:
Nanocarriers Market Demand Drivers: What’s Powering Industry Growth?
The expanding requirement for personalized medicines is projected to boost the expansion of the nanocarriers market moving ahead. Personalized medicine involves customizing medical care to each patient’s unique attributes, specifically utilizing genetic, biomarker, and molecular data. The heightened focus on personalized medicine is due to its capacity to allow physicians to customize cancer treatments according to a patient’s genetic profile, thereby enhancing efficacy and minimizing adverse effects. Nanocarriers facilitate personalized medicine by delivering medications precisely to specific patient targets, regulating their release, improving their absorption, and enabling customized combination therapies based on individual biological profiles. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the United States Food and Drug Administration (FDA) sanctioned 16 novel personalized therapies for patients with rare diseases, a significant jump from only six approvals in 2022. Consequently, the increasing need for personalized medicines is propelling the growth of the nanocarriers market.
Nanocarriers Market Segment Analysis And Revenue Potential
The nanocarriers market covered in this report is segmented –
1) By Type: Polymeric Nanocarriers, Lipid-Based Nanocarriers, Inorganic Nanocarriers, Other Types
2) By Application: Drug Delivery, Diagnostics, Vaccines, Gene Therapy, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Polymeric Nanocarriers: Nanoparticles Of Poly Lactic Acid, Nanoparticles Of Poly Lactic-Co-Glycolic Acid, Nanoparticles Of Chitosan, Nanoparticles Of Gelatin, Nanoparticles Of Polycaprolactone
2) By Lipid-Based Nanocarriers: Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Liposomes, Nanoemulsions, Self-Emulsifying Drug Delivery Systems
3) By Inorganic Nanocarriers: Gold Nanoparticles, Silver Nanoparticles, Silica Nanoparticles, Magnetic Nanoparticles, Quantum Dots
4) By Other Types: Dendrimers, Protein-Based Nanocarriers, Carbon Nanotubes, Nanocrystals, Exosomes
Nanocarriers Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies within the nanocarriers market are focusing on developing sophisticated formulations, notably lipid nanoparticle technologies, to enhance the precision of drug delivery and improve therapeutic outcomes. Lipid nanoparticle technologies are microscopic, fat-based carriers designed for the secure and efficient transport of drugs or genetic therapies to designated cells or tissues. For instance, in July 2023, Cytiva, a US-based biotechnology company, launched its NanoAssemblr commercial formulation system, an automated, single-use platform designed to support the entire spectrum of clinical and commercial manufacturing for lipid nanoparticle (LNP) medicines. This system utilizes Cytiva’s NxGen technology to ensure controlled and consistent mixing, thereby maintaining uniform quality from early research stages through to large-scale manufacturing under cGMP conditions. The platform minimizes the risk of cross-contamination through its single-use fluid path and supports the efficient production of multiple products within one facility. Furthermore, it features intuitive software compliant with regulatory standards, which automates workflows and enables electronic batch records, thereby streamlining the production of genomic medicines such as mRNA vaccines, gene therapies, and cancer vaccines.
Nanocarriers Market Key Players Shaping Industry Direction
Major companies operating in the nanocarriers market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, Amgen Inc., Evonik Industries AG, Matinas BioPharma Holdings Inc., Luye Pharma Group Ltd., Ascendia Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., Nanobiotix S.A., Polymun Scientific Immunbiologische Forschung GmbH, ReCode Therapeutics Inc., Celsion Corporation, Starpharma Holdings Limited, EnGeneIC Ltd., Acuitas Therapeutics Inc., Altamira Therapeutics Ltd., Nanexa AB
View The Full Nanocarriers Market Report:
Nanocarriers Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the nanocarriers market in 2025. The regions covered in the nanocarriers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
